Home > Press releases > Archives Health >  Partnership with the Institut National de la Santé et de la Recherche Médicale (INSERM) to combat Bilharziosis
Partnership with the Institut National de la Santé et de la Recherche Médicale (INSERM) to combat Bilharziosis

14-01-2009-

A partnership and financing agreement has just been signed between the Principality of Monaco and the French institute, INSERM, to lend support to research work, called Bilhvax 3, for the development of a vaccination against bilharziosis, the second major parasitic disease after malaria.

In a similar vein to the programmes implemented in Mali and Niger to combat sickle cell disease, this new partnership demonstrates the intent of the Monaco Government, via its international development cooperation, to take action within the field of neglected diseases which still affect a billion people in the most underprivileged countries.

It is estimated that the disease, due to the horrendous lesions it causes (renal failure, cancer…) kills over 280 000 people and infects over 200 million people worldwide every year.

It develops more particularly in Sub-Saharan Africa where there is a lack of heath facilities and access to drinking water.

Currently the only existing treatment, chemotherapy, is limited (expensive, does not protect against new contamination...). The vaccination is therefore the most sustainable solution.

The agreement, for a five-year period, allows for funding from Monaco amounting to 425 000€, the total cost of the project representing over 10 million euros. Other financial sponsors include the French Ministry of Foreign Affairs and the Northern Pas de Calais Regional Council.

With the view of testing the effects of the candidate vaccine, clinical trials are being carried out on a population living on the banks of the Senegal River, greatly affected due to the construction of weirs and the major development of irrigation systems, and efficiency tests continued.

Once the clinical trials have been successfully completed with a satisfactory immune response in children causing no serious side effects and the final phase commenced, the vaccination could be accepted by the European Medicines Agency (EMEA) and used by International Organisations (WHO, UNESCO…) for the benefit of the most underprivileged populations.


Contact:
The Department of External Relations
Office of International Cooperation (+377 98 98 44 88 )

Find all the latest news from the Office of International Cooperation
on the website www.cooperation-monaco.gouv.mc
Archives Health
-Open Day at the Nursing College
- Partnership with the Institut National de la Santé et de la Recherche Médicale (INSERM) to combat Bilharziosis
-Yellow Fever Vaccine in the Principality
-Prevention campaign Thursday 19th and Friday 20th February 2009 at the Salle des Variétés
-The Director General of the World Health Organisation on visit to the Principality
-Revolutionary medical equipment at the CHPG
-Press release – Influenza A/H1N1 6th May 2009
-Press release
-The Principality of Monaco takes part in the 62nd World Health Assembly
-Opening of Paediatric Emergency Department
- A/H1N1 Influenza
-Communication campaign against the dangers of alcoholism
-HEALTH TIPS, EXTREME HEAT: RISK PREVENTION
-A case of A/HI/NI flu
-Cardiac emergency: learn how to save a life with the IFSI
-Status report – A/H1 N1 Flu
-Looking after children at home who are ill
-Announcement by the Department of Health and Social Affairs
-Presentation of the vaccination campaign against influenza AH1N1
-1st December 2009, World AIDS Day Auction in aid of Fight Aids Monaco
-Opening of the A Qietüdine establishment
-INFLUENZA A/ H1 N1 VACCINATION
-A (H1 N1) INFLUENZA VACCINE
-A Qietüdine: Opening of the home and submission of applications
-Partnership between CHPG – Government of Monaco Two doctors and a nurse from the developing countries currently on a training course in Monaco
-New prospects for the future Princess Grace Hospital
- Increased control of Aedes Albopictus known as the “Asian tiger mosquito”
-CHPG Nurse Training Institute (IFSI): registration for the entrance examination begins on 1st December
-Large-scale free osteoporosis screening campaign
-Human Papillomavirus vaccination campaign
Last updated: April 28, 2009 (12:29) Copyright © 2014 Service Informatique du Ministère d'Etat www.gouv.mc